RESET PHARMACEUTICALS
Reset Pharma is a biotechnology company that focuses on the development and commercialization of novel psychedelic treatments for patients with life-threatening illnesses, including cancer. Its program focuses on psilocybin with psychotherapy for patients with cancer-related demoralization, anxiety, and depression.
RESET PHARMACEUTICALS
Industry:
Biotechnology Health Care Medical
Website Url:
http://www.resetpharma.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
11.12 M USD
Similar Organizations
Dauntless Pharmaceuticals
Dauntless Pharmaceuticals is a biotechnology company that focuses on the development of drugs.
Montecito Bio Sciences, Ltd.
Bio-medical diagnostics company focused on the development and exploitation of a proprietary diagnostic and monitoring platform.
Official Site Inspections
http://www.resetpharma.com
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Reset Pharmaceuticals"
Reset Pharma
Reset Pharma is a neuro-biotechnology company dedicated to improving mental health through novel pathways. We exist to help people move beyond the psychological trauma of a life …See details»
Our Focus – Reset Pharma
Reset Pharma is addressing demoralization syndrome in patients suffering from cancer by bringing science to psilocybin. What is demoralization syndrome? Demoralization syndrome is a significant mental health condition …See details»
Our Team – Reset Pharma
Our leadership team is composed of scientific and strategic professionals at the forefront of CNS research & development and commercialization, and is strengthened further by leaders in psychology, psychiatry, psychedelics, and …See details»
Reset Pharmaceuticals - Crunchbase Company Profile & Funding
Reset Pharma is a biotechnology company that focuses on the development and commercialization of novel psychedelic treatments for patients with life-threatening illnesses, …See details»
Reset Pharmaceuticals - LinkedIn
Reset Pharma is a privately-held biotechnology company focused on the development and commercialization of novel psychedelic treatments for patients with life-threatening illnesses, …See details»
Reset Pharma - VentureRadar
Website: https://www.resetpharma.com/ Reset Pharma is a privately held, US-based biotechnology company developing and commercializing novel clinical-stage treatments for …See details»
Reset Pharma - BIO International Convention | BIO
Jun 5, 2023 · Clinical Stage Neuro Biotechnology company bringing science to Psilocybin to help people raise above a life altering diagnosis. Initial focus is on patients with cancer suffering …See details»
Reset Pharmaceuticals Enters into Exclusive Worldwide
Jul 7, 2021 · Reset Pharma is a privately-held biotechnology company developing and commercializing novel psychedelic treatments for patients with life-threatening illnesses, …See details»
Reset Pharma Company Profile 2024: Valuation, Funding
Information on valuation, funding, cap tables, investors, and executives for Reset Pharma. Use the PitchBook Platform to explore the full profile.See details»
Stephen Ross, M.D., Chair of Reset Pharma’s Scientific
Oct 14, 2021 · Reset Pharma is a privately held biotechnology company developing and commercializing novel psychedelic treatments for patients with life-threatening illnesses, …See details»
Reset Pharmaceuticals Announces Appointment of Neuroscience …
Nov 2, 2022 · Reset Pharmaceuticals, Inc. (Reset Pharma), a privately held biotechnology company focused on the development and commercialization of novel clinical-stage …See details»
Reset Pharmaceuticals Appoints Innes Meldrum as President
Jan 5, 2023 · Reset Pharma is a privately held, US-based biotechnology company developing and commercializing novel clinical-stage treatments for patients suffering from mental illness …See details»
Reset Pharmaceuticals - Overview, News & Similar companies
View Reset Pharmaceuticals (www.resetpharma.com) location in New York, United States , revenue, industry and description. Find related and similar companies as well as employees …See details»
Reset Pharmaceuticals announces appointment of neuroscience …
NEW YORK, Nov. 02, 2022 (GLOBE NEWSWIRE) -- Reset Pharmaceuticals, Inc. (Reset Pharma), a privately held biotechnology company focused on the development and …See details»
Reset Pharmaceuticals Enters into Exclusive Worldwide License …
Jul 7, 2021 · Transaction accelerates Reset Pharmaceuticals’ lead psilocybin program, targeting severe demoralization, as well as anxiety, and depression, in cancer patients. Stephen Ross, …See details»
2022 - Reset Pharma
Nov 2, 2022 · Reset Pharmaceuticals, Inc. (Reset Pharma), a privately held biotechnology company focused on the development and commercialization of novel clinical-stage …See details»
Recommended Stories - Yahoo Finance
NEW YORK, July 07, 2021 (GLOBE NEWSWIRE) -- Reset Pharmaceuticals, Inc. (Reset Pharma) a privately-held biotechnology company focused on developing and commercializing …See details»
Reset Pharma | VentureRadar
Website: https://www.resetpharma.com/ Reset Pharma is a privately held, US-based biotechnology company developing and commercializing novel clinical-stage treatments for …See details»
Stephen Ross, M.D., Chair of Reset Pharma’s Scientific Advisory …
Oct 14, 2021 · Reset Pharmaceuticals, Inc. (Reset Pharma) announced today that Stephen Ross, M.D., Chair of Reset Pharma’s Scientific Advisory Board, will deliver a keynote presentation at …See details»
Reset Pharma Receives Notice of Safe to Proceed from FDA for ...
Nov 1, 2023 · Reset Pharma is a privately held, clinical-stage biotechnology company focused on developing and commercializing novel treatments for patients suffering from mental illness …See details»